1. ScholarBank@NUS
  2. 1. Staff
  3. Staff Publications
Please use this identifier to cite or link to this item: https://doi.org/10.1080/21645515.2019.1661204
DC FieldValue
dc.titleImmunogenicity and safety of a dengue vaccine given as a booster in Singapore: a randomized Phase II, placebo-controlled trial evaluating its effects 5?6 years after completion of the primary series
dc.contributor.authorEujung Juliana Park
dc.contributor.authorSophia Archuleta
dc.contributor.authorMay-Lin Helen Oh
dc.contributor.authorLynette P Shek
dc.contributor.authorJing Jin
dc.contributor.authorMatthew Bonaparte
dc.contributor.authorCarina Fargo
dc.contributor.authorAlain Bouckenooghe
dc.date.accessioned2020-05-12T03:51:23Z
dc.date.available2020-05-12T03:51:23Z
dc.date.issued2019-11-05
dc.identifier.citationEujung Juliana Park, Sophia Archuleta, May-Lin Helen Oh, Lynette P Shek, Jing Jin, Matthew Bonaparte, Carina Fargo, Alain Bouckenooghe (2019-11-05). Immunogenicity and safety of a dengue vaccine given as a booster in Singapore: a randomized Phase II, placebo-controlled trial evaluating its effects 5?6 years after completion of the primary series. Human Vaccines & Immunotherapeutics 16 (3) : 523-529. ScholarBank@NUS Repository. https://doi.org/10.1080/21645515.2019.1661204
dc.identifier.issn21645515
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/167996
dc.publisherTaylor & Francis
dc.sourceTaylor & Francis
dc.typeArticle
dc.contributor.departmentMEDICINE
dc.contributor.departmentPAEDIATRICS
dc.description.doi10.1080/21645515.2019.1661204
dc.description.sourcetitleHuman Vaccines & Immunotherapeutics
dc.description.volume16
dc.description.issue3
dc.description.page523-529
Appears in Collections:Elements
Staff Publications

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10.108021645515.2019.1661204.zip1.04 MBZIP

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.